OpenVSafe by OpenVAERS
Search V-safe

AVS-18965-13029

2 vaccinations 6 coded responses 26 check-ins 6 free-text entries 0 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
025 / MA
Registered
2021-02-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-08
    Registered in v-safe
  2. 2021-02-08
    Dose 1 — Moderna
  3. 2021-02-08
    Health check-in — day 0, dose 1
    Feeling: Fair · Headache, Nausea
    Adult check-in
  4. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  5. 2021-02-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-02-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dry throat, Headache, Nasal discomfort, Nasal dryness, Paranasal sinus discomfort — Feeling: Fair · Headache
    Free text: Nasopharyngeal dryness/irritation. Frontal Sinus pressure/ headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-14
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dry throat, Headache, Nasal discomfort, Nasal dryness, Paranasal sinus discomfort, Throat irritation — Feeling: Good
    Free text: Frontal sinus pressure/headache. Nasopharyngeal dryness/irritation. Stable fro yesterday. Call
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-03
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-03-08
    Dose 2 — Moderna
  14. 2021-03-08
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Nausea
    Adult check-in
  16. 2021-03-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  17. 2021-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-03-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pain — Feeling: Good
    Free text: Mild/insignificant residual soreness at injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Neuropathy peripheral, Pre-existing disease — Feeling: Good
    Free text: Peripheral neuropathy in my feet seems worse than prior to 2nd shot. Not sure if there is a teal cause and effect.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good
    Free text: 2019 Dx GBS. Post 2nd COVID shot increased pain / hypersensitivity ( neuropathy) feet primarily and to a lesser degree below knees. Improving.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-15
    Survey response — day 7, dose 2
    MedDRA: Neuropathy peripheral — Feeling: Good
    Free text: Continued foot neuropathy since 2nd injection. Slightly improved.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-12
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-19
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-06-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-09-06
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2022-03-08
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-08Moderna
22021-03-08Moderna

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-13

Systemic reaction (other): Nasopharyngeal dryness/irritation. Frontal Sinus pressure/ headache

2021-02-14

Systemic reaction (other): Frontal sinus pressure/headache. Nasopharyngeal dryness/irritation. Stable fro yesterday. Call

Release 5 — days 1–6 daily, dose 2

2021-03-12

Systemic reaction (other): Mild/insignificant residual soreness at injection site.

2021-03-13

Systemic reaction (other): Peripheral neuropathy in my feet seems worse than prior to 2nd shot. Not sure if there is a teal cause and effect.

2021-03-14

Systemic reaction (other): 2019 Dx GBS. Post 2nd COVID shot increased pain / hypersensitivity ( neuropathy) feet primarily and to a lesser degree below knees. Improving.

Release 5 — day 7, dose 2

2021-03-15

Systemic reaction (other): Continued foot neuropathy since 2nd injection. Slightly improved.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROCondition aggravated ✓ ✓ ✓
SRODry throat ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SRONasal discomfort ✓ ✓ ✓
SRONasal dryness ✓ ✓ ✓
SRONeuropathy peripheral ✓ ✓ ✓
SROParanasal sinus discomfort ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROThroat irritation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release